Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,575.64
(
-0.61%
)
News Focus
News Focus
Post# of 257579
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rkrw

Send PM Follow Ignore
Followers 45
Posts 3206
Boards Moderated 0
Alias Born 12/29/2003

rkrw

Member Level

Re: DewDiligence post# 74100

Monday, 03/09/2009 9:02:59 AM

Monday, March 09, 2009 9:02:59 AM

Post# of 257579
Every data point including side effects and dropout rates weren't in their favor. Further, assuming telapravir gets approved all its data is with Pegasys. I'm not completely sure approval will be a cinch. Either way look for Albuferon to be a commercial flop.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today